Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures.
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex.
Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: an open label study.
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.
[Translation and cross-cultural adaptation of the Multiple Sclerosis Walking Scale (MSWS-12) into Brazilian Portuguese].
The effects of heat stress on physical functioning in persons with multiple sclerosis.
[Neuromyelitis optica: a case report].
Automatic Lesion Incidence Estimation and Detection in Multiple Sclerosis Using Multisequence Longitudinal MRI.
Defining Mild, Moderate, and Severe Pain in Persons with Multiple Sclerosis.
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Neural stem cell diversity and proteomics.
Quality improvement and practice-based research in neurology using the electronic medical record.
Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients - preliminary study.
Abnormal white matter properties in adolescent girls with anorexia nervosa.
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
Treatment of chronic inflammatory polyneuropathy may improve associated hearing loss: A case report and a review of the literature.
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
Suppression of the lipid peroxidation process in the CNS reduces neurological expression of experimentally induced autoimmune encephalomyelitis.
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study.
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
Pages
« first
‹ previous
…
273
274
275
276
277
278
279
280
281
…
next ›
last »